1. Home
  2. ASND vs FCN Comparison

ASND vs FCN Comparison

Compare ASND & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • FCN
  • Stock Information
  • Founded
  • ASND 2006
  • FCN 1982
  • Country
  • ASND Denmark
  • FCN United States
  • Employees
  • ASND N/A
  • FCN N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • FCN Professional Services
  • Sector
  • ASND Health Care
  • FCN Consumer Discretionary
  • Exchange
  • ASND Nasdaq
  • FCN Nasdaq
  • Market Cap
  • ASND 7.7B
  • FCN 7.0B
  • IPO Year
  • ASND 2015
  • FCN 1996
  • Fundamental
  • Price
  • ASND $152.43
  • FCN $164.95
  • Analyst Decision
  • ASND Strong Buy
  • FCN Strong Buy
  • Analyst Count
  • ASND 14
  • FCN 1
  • Target Price
  • ASND $197.36
  • FCN $275.00
  • AVG Volume (30 Days)
  • ASND 519.7K
  • FCN 226.4K
  • Earning Date
  • ASND 02-12-2025
  • FCN 02-20-2025
  • Dividend Yield
  • ASND N/A
  • FCN N/A
  • EPS Growth
  • ASND N/A
  • FCN 1.30
  • EPS
  • ASND N/A
  • FCN 7.81
  • Revenue
  • ASND $376,478,932.00
  • FCN $3,698,652,000.00
  • Revenue This Year
  • ASND $47.51
  • FCN $7.62
  • Revenue Next Year
  • ASND $88.30
  • FCN $4.98
  • P/E Ratio
  • ASND N/A
  • FCN $21.01
  • Revenue Growth
  • ASND 36.34
  • FCN 6.00
  • 52 Week Low
  • ASND $111.09
  • FCN $161.24
  • 52 Week High
  • ASND $161.00
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • ASND 66.26
  • FCN 22.61
  • Support Level
  • ASND $118.03
  • FCN $186.82
  • Resistance Level
  • ASND $157.37
  • FCN $190.69
  • Average True Range (ATR)
  • ASND 6.50
  • FCN 4.98
  • MACD
  • ASND 3.62
  • FCN -2.95
  • Stochastic Oscillator
  • ASND 87.44
  • FCN 10.29

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: